Suppr超能文献

阿沙替利单抗

Axatilimab.

作者信息

Levien Terri L, Baker Danial E

机构信息

College of Pharmacy, Washington State University, Spokane, WA, USA.

Washington State University, Spokane, WA, USA.

出版信息

Hosp Pharm. 2025 Jan 9:00185787241310874. doi: 10.1177/00185787241310874.

Abstract

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy and Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of publishes selected reviews in this column. For more information about , contact Wolters Kluwer customer service at 866-397-3433.

摘要

每月,订阅者会收到5至6篇关于新发布或处于3期临床试验后期阶段药物的详细专题论文。这些专题论文面向药学与治疗学委员会。订阅者还会每月收到1页关于对议程以及药房/护理在职培训有用药物的简要专题论文。每月还会提供一份全面的目标药物利用评估/药物使用评估(DUE/MUE)。订阅后,专题论文可供订阅者在线获取。专题论文可进行定制以满足机构的需求。通过合作,[此处原文似乎不完整]在本专栏发表精选评论。如需了解更多关于[此处原文似乎不完整]的信息,请致电866 - 397 - 3433联系威科集团客户服务。

相似文献

1
Axatilimab.
Hosp Pharm. 2025 Jan 9:00185787241310874. doi: 10.1177/00185787241310874.
2
Formulary Drug Reviews: Glecaprevir/Pibrentasvir.
Hosp Pharm. 2018 Apr;53(2):75-84. doi: 10.1177/0018578717746417. Epub 2017 Dec 11.
3
Formulary Drug Review: Edaravone.
Hosp Pharm. 2017 Dec;52(11):732-736. doi: 10.1177/0018578717734877. Epub 2017 Oct 9.
4
Formulary Drug Review: Odevixibat.
Hosp Pharm. 2023 Apr;58(2):125-133. doi: 10.1177/00185787211069036. Epub 2022 Feb 8.
5
Formulary Drug Review: Belumosudil.
Hosp Pharm. 2022 Aug;57(4):435-441. doi: 10.1177/00185787211061381. Epub 2021 Dec 7.
6
Formulary Drug Review: Ocrelizumab.
Hosp Pharm. 2017 Oct;52(9):599-606. doi: 10.1177/0018578717731733. Epub 2017 Sep 17.
7
Formulary Drug Review: Rezafungin.
Hosp Pharm. 2024 Jun;59(3):245-253. doi: 10.1177/00185787231206523. Epub 2023 Oct 30.
8
Formulary Drug Reviews: Terlipressin.
Hosp Pharm. 2023 Dec;58(6):544-548. doi: 10.1177/00185787221150921. Epub 2023 Jan 26.
9
Formulary Drug Reviews: Nirsevimab.
Hosp Pharm. 2024 Apr;59(2):138-145. doi: 10.1177/00185787231212620. Epub 2023 Nov 19.
10
Levoketoconazole.
Hosp Pharm. 2022 Oct;57(5):605-614. doi: 10.1177/00185787221115368. Epub 2022 Aug 2.

引用本文的文献

1
Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons.
Pulm Ther. 2025 Jun;11(2):195-234. doi: 10.1007/s41030-025-00296-0. Epub 2025 May 5.

本文引用的文献

1
Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD.
Cells. 2024 Sep 11;13(18):1524. doi: 10.3390/cells13181524.
2
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537.
3
Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease.
Adv Hematol. 2023 Dec 6;2023:9949961. doi: 10.1155/2023/9949961. eCollection 2023.
5
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.
J Clin Invest. 2014 Oct;124(10):4266-80. doi: 10.1172/JCI75935. Epub 2014 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验